Go to main page
Bioduro Go to mainpage

Webinar Series

Advances in Drug Formulation & Delivery

Accelerated Development • Enhanced Bioavailability
Continuous Processing • Oral Delivery of Biologics

Join us at this virtual conference to learn about new insights and advances in the area of drug formulation & delivery. Even the most promising API can have development challenges that require innovative solutions to reach its final drug product. Our virtual conference will address four of these areas with tracks on the following: Accelerated Development, Enhanced Bioavailability, Continuous Processing, Oral Delivery of Biologics.

REGISTER NOW

Upcoming Events

Tuesday, September 1st

9:00am PDT

Dr. Dedong Wu

Senior Scientist at AstraZeneca
Improving Bioavailability by Prodrug Approach

Tuesday, September 8th

9:00am PDT

Jim Marjeram

Technology Director at O’Hara Tech
Advantages of Continuous Tablet Coating



FULL AGENDA

REGISTER NOW


Accelerated Development: Fast path to the clinic Enhanced Bioavailability Continuous Processing Oral Delivery of Biologics
Discovery & preclinical approaches that enable rapid development Approaches that enhance solubility of challenging API to enable clinically viable formulations Topics covered will include uses of technologies such as: amorphous solid dispersion, continuous granulation, coating and extrusion Innovative approaches to address oral delivery of biologics, including: proteins, peptides, nucleic acids, and beyond

Dr. Daniel Treffer, Melt Prep (More Info)
Rapid and lossless prototyping of HME formulations in the milligram to gram scale via Vacuum Compression Molding – June 30th

View recording
Q&A

Dr. Chad Brown, Merck (More Info)
Hot Melt Extrusion as a Key Enabler of Developing Products of Low Solubility Compounds – June 2nd

Q&A

Dr. Xiaohu Deng, Viracta (More Info)
Phase-appropriate CMC Strategies in Drug Product Development – July 14th

View recording
Q&A

Chandra Kelley, Pfanstiehl (More Info)
Key Considerations in Accelerating Biopharma Formulation Development – August 11th

Seth Forster, Merck (More Info)
Long-Acting Implants: Design for Durable Drug Delivery – August 4th

View recording
Q&A

Dr. John Shelley, Schrodinger (More Info)
Formulation Development for Small Molecules and Biologics Enhancements with Molecular Modeling – July 28th

View recording
Q&A

Dr. Andrea Browning, Schrodinger (More Info)
Formulation Development for Small Molecules and Biologics Enhancements with Molecular Modeling – July 28th

View recording
Q&A

Dr. Harsh Chauhan, Creighton University (More Info)
Formulation Considerations for development of Ternary Solid Dispersions – June 23rd

View recording
Q&A

Dr. Dedong Wu, Astrazeneca (More Info)
Improving Bioavailability by Prodrug Approach – September 1st

View recording

Dr. Feng Zhang, UT Austin (More Info)
Hot-melt extrusion to prepare amorphous solid dispersions: key concepts and common misperceptions – July 7th

View recording
Q&A

Dr. Yi-Ling Hsieh, AbbVie (More Info)
Lipid-Based Formulation – The Impact on Biopharmaceutics and Patient Centricity – July 21st

View recording
Q&A

Dr. Abu Serajuddin, St. John’s University (More Info)
Development of HPMCAS-based amorphous solid dispersions by melt extrusion 21st – August 18th

View recording

Dr. Michael Thompson, McMaster University (More Info)
Developments in Twin-Screw Granulation – May 26th

View recording
Q&A

Andy Birkmire, GEA (More Info)
Successful Strategies for Developing a Continuous Manufacturing Process – June 9th

View recording
Q&A

Jim Marjeram, O’Hara (More Info)
Advantages of Continuous Tablet Coating – September 8th

View recording
Q&A

Dr. John Vrettos, Enteris BioPharma (More Info)
Breaking Through the Barriers of Oral Biologics – June 16th


View recording

Q&A



Accelerated Development: Fast path to the clinic Discovery & preclinical approaches that enable rapid development

Dr. Daniel Treffer, Melt Prep (More Info)
Rapid and lossless prototyping of HME formulations in the milligram to gram scale via Vacuum Compression Molding – June 30th

View recording
Q&A

Dr. Chad Brown, Merck (More Info)
Hot Melt Extrusion as a Key Enabler of Developing Products of Low Solubility Compounds – June 2nd

Q&A

Dr. Xiaohu Deng, Viracta (More Info)
Phase-appropriate CMC Strategies in Drug Product Development – July 14th

View recording
Q&A

Chandra Kelley, Pfanstiehl (More Info)
Key Considerations in Accelerating Biopharma Formulation Development – August 11th

Seth Forster, Merck (More Info)
Long-Acting Implants: Design for Durable Drug Delivery – August 4th

View recording
Q&A

Dr. John Shelley, Schrodinger (More Info)
Formulation Development for Small Molecules and Biologics Enhancements with Molecular Modeling – July 28th

View recording
Q&A

Dr. Andrea Browning, Schrodinger (More Info)
Formulation Development for Small Molecules and Biologics Enhancements with Molecular Modeling – July 28th

View recording
Q&A

Dr. Raimar Löbenberg, University of Alberta (More Info)
Presentation title coming soon – Date TBD

Enhanced Bioavailability Approaches that enhance solubility of challenging API to enable clinically viable formulations

Dr. Harsh Chauhan, Creighton University (More Info)
Formulation Considerations for development of Ternary Solid Dispersions – June 23rd

View recording
Q&A

Dr. Dedong Wu, Astrazeneca (More Info)
Improving Bioavailability by Prodrug Approach – September 1st

View recording

Dr. Feng Zhang, UT Austin (More Info)
Hot-melt extrusion to prepare amorphous solid dispersions: key concepts and common misperceptions – July 7th

View recording
Q&A

Dr. Mo Maniruzzaman, UT Austin (More Info)
3D printing and state-of-the-art manufacturing techniques to advance drug delivery – Date TBD

Dr. Yi-Ling Hsieh, AbbVie (More Info)
Lipid-Based Formulation – The Impact on Biopharmaceutics and Patient Centricity – July 21st

View recording
Q&A

Dr. Abu Serajuddin, St. John’s University (More Info)
Development of HPMCAS-based amorphous solid dispersions by melt extrusion 21st – August 18th

View recording

Continuous Processing Topics covered will include uses of technologies such as: amorphous solid dispersion, continuous granulation, coating and extrusion

Dr. Michael Thompson, McMaster University (More Info)
Developments in Twin-Screw Granulation – May 26th
View recording
Q&A

Andy Birkmire, GEA (More Info)
Successful Strategies for Developing a Continuous Manufacturing Process – June 9th
View recording Q&A

Jim Marjeram, O’Hara (More Info)
Advantages of Continuous Tablet Coating – September 8th

View recording
Q&A

Oral Delivery Innovative approaches to address oral delivery of biologics, including: proteins, peptides, nucleic acids, and beyond

Dr. John Vrettos, Enteris BioPharma (More Info)
Breaking Through the Barriers of Oral Biologics – June 16th
View recording
Q&A

Dr. Stephen Hoag, University of Maryland (More Info)
Presentation title coming soon – Date TBD



REGISTER NOW